CannTrust Holdings Inc. will begin trading on the CSE very soon. Since the company's inception in 2014, CannTrust has led the Canadian market in producing pharmaceutically standardized product. As a Health Canada licensed producer, CannTrust currently operates a 50,000 square foot state-of-the-art hydroponic cannabis cultivation facility in Vaughan, Ontario and is upgrading a 430,000 square foot cultivation facility in the Niagara region.
Here's all the details for interested investors and traders:
CannTrust is set to begin trading on the CSE on Monday, August 21st.
CannTrust's state-of-the-art 50,000 sq. foot ACMPR licensed production facility is located in Vaughan, Ontario.
Soon, CannTrust will be upgrading a 430,000 square foot cultivation facility in the Niagara region.
CannTrust currently has approximately 25,000 active patients.
CannTrust's Adjusted EBITDA was positive in Q1'17
Q2 Financials will be released on August 29th
They've never had any product recalls
All of CannTrust's products are pesticide-free
CannTrust will be trading on the CSE under the symbol TRST.
There are 86,862,799 shares of CannTrust issued and outstanding.
There are 5,164,188 shares of CannTrust reserved for issuance.
CannTrust CUSIP is 137800 20 7.
CannTrust's ISIN is CA137800 20 7 7.
CannTrust's transfer agent is TSX Trust Company.
Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important cannabis update. Also, be sure to connect with The Daily Marijuana Observer via social media on Facebook, Twitter, and Instagram.